NutriStem™ hPSC XF Culture Medium for Human iPS and ES Cells
01-0005 / 01-0005-100
Brand: NutriStem
NutriStem hPSC XF Culture Medium is a fully-defined, xeno-free, low growth factor concentration, feeder-free culture medium for human embryonic stem (ES) and induced pluripotent stem (iPS) cells. Cells can be cultured for at least 20 passages while retaining pluripotency marker expression, robust proliferation with a normal karyotype, and the ability to differentiate into cells of all three germ layers in vitro and in vivo.
Note: shown do not include shipping and handling charges.
Product Information
Morphology of Human H1 ES cells Grown in NutriStem hPSC XF Medium for 20 passages.
Expression of Pluripotency Markers in hES Cells Cultured in NutriStem hPSC XF medium.
Proliferation Growth Rate of Human H1 ES cells Cultured in NutriStem hPSC XF Medium versus Competitor Medium.
The Sartorius company name and logo are the property of Sartorius AG, Germany.
- StemRNA 3rd Gen Reprogramming Kit
- StemRNA-SR Reprogramming Kit
- CryoStem Freezing Medium
01-0005 Specifications Sheet
Safety Data Sheets:
Product Flyers:
Protocols:
Application Notes:
Devito LG; Cooper F; D'Angelo I; Smith J; Healy L. Generation of FOUR iPSC lines (CRICKi004-A; CRICKi005-A; CRICKi006-A, CRICKi007-A) from Spinal muscle atrophy patients with lower extremity dominant (SMALED) phenotype. Stem Cell Res 65:102954 (2022). Miyake T; Kuge M; Matsumoto Y; Shimada M. α-glucosyl-rutin activates immediate early genes in human induced pluripotent stem cells. Stem Cell Res 56:102511 (2021). Alowaysi M; Astro V; Fiacco E; Alzahrani F; Alkuraya FS; Adamo A. Generation of iPSC lines (KAUSTi011-A, KAUSTi011-B) from a Saudi patient with epileptic encephalopathy carrying homozygous mutation in the GLP1R gene. Stem Cell Res 50:1021 (2021). Fiacco E; Alowaysi M; Astro V; Adamo A. Derivation of two naturally isogenic iPSC lines (KAUSTi006-A and KAUSTi006-B) from a mosaic Klinefelter Syndrome patient (47-XXY/46-XY). Stem Cell Res 49:102049 (2020). Alowaysi M; Fiaccdo E; Astro V; Adamo A. Establishment of an iPSC cohort from three unrelated 47-XXY Klinefelter Syndrome patients (KAUSTi007-A, KAUSTi007-B, KAUSTi009-A, KAUSTi009-B, KAUSTi010-A, KAUSTi010-B). Stem Cell Res 49:102042 (2020). Nowak-Imialek M; Wunderlich S; Herrmann D; Breitschuh-Leibling S; Cohring C; Petersen J; Klein S; Baulain U; Lucas-Hahn A; Martin U; Niemann H. In Vitro and In Vivo Interspecies Chimera Assay Using Early Pig Embryos. Cellular Reprogramming 22:doi.org/10.1089/cell.2019.0107 (2020). Alowaysi M; Fiacco E; Astro V; Adamo A. Establishment of iPSC lines from a high-grade Klinefelter Syndrome patient (49-XXXXY) and two genetically matched healthy relatives (KAUSTi003-A, KAUSTi004-A, KAUSTi004-B, KAUSTi005-A, KAUSTi005-B, KAUSTi005-C). Stem Cell Res 49:102008 (2020). Kathuria A; Lopez-Lengowski K; Vater M; McPhie D; Cohen BM Karmacharya R. Transcriptome analysis and functional characterization of cerebral organoids in bipolar disorder. Genome Medicine 12:34 (2020). Lee J; Bignone PA; Coles SL; Liu Y; Snyder E; Larcoca D. Induced pluripotency and spontaneous reversal of cellular aging in supercentenarian donor cells. Biochem Biophys Res Commun in press:https://doi.org/10.1016/j.bbrc.2020.02.092 (2020). Shimada M; Tsukada K; Kagawa N; Matsumoto Y. Reprogramming and differentiation-dependent transcriptional alteration of DNA damage response and apoptosis genes in human induced pluripotent stem cells. J Radiation Res 2019:1-10 (2019). Brodaczewska KK; Nielcka ZF; Maliszewska-Olejniczak K; Szxzylik C; Porta C; Bartnik W; Czarnecka AM. Metastatic renal cell carcinoma cells growing in 3D on poly‑D‑lysine or laminin present a stem‑like phenotype and drug resistance. Oncology Reports in press:2402 (2019). Bredenkamp N; Yang J; Clarke J; Stirparo GG; von Meyenn F; Baker D; Drummond R; Ren Y; Li D; Wu C; Rostovskaya M; Eminli-Meissner S; Smith A; Guo G. Wnt Inhibition Facilitates RNA-Mediated Reprogramming of Human Somatic Cells to Naive Pluripotency. Stem Cell Rep 13:1083 (2019). Nakajima M; Yoshimatsu S; Sato T; Nakamura M; Okahara J; Sasaki E; Shiozawa S; Okano H. Establishment of induced pluripotent stem cells from common marmoset fibroblasts by RNA-based reprogramming. Biochem Biophys Research Commun in press:https://doi.org/10.1016/j.bbrc.2019.05.175 (2019). Liu L-P; Li Y-M; Guo N-N; LI S; Ma X; Zhang Y-X; Gao Y; Huang J-L; Zheng D-X; Wang L-Y; Xu H; Hui L; Zheng Y-W. Therapeutic Potential of Patient iPSC-Derived iMelanocytes in Autologous Transplantation. Cell Reports 27:455-466.e5 (2019). Sacco AM; Belviso I; Romano V; Carfora A; Schonauer F; Nurzynska D; Montagnani S; Di Meglio F; Castaldo C. Diversity of dermal fibroblasts as major determinant of variability in cell reprogramming. J Cell Mol Med :1-13; https://doi.org/10.1111/jcmm.14316 (2019). Nishishita N; Muramatsu M; Kawamata S. An effective freezing/thawing method for human pluripotent stem cells cultured in chemically-defined and feeder-free conditions. A J Stem Cells 4:38 (2015). Klein T; Klug K; Henkel L; Kwok CK; Edenhofer F; Klopocki E; Kurth I; Üceyler N. Generation of two induced pluripotent stem cell lines from skin fibroblasts of sisters carrying a c.1094C>A variation in the SCN10A gene potentially associated with small fiber neuropathy. Stem Cell Res 35:101396 (2019). Supharattanasitthi W; Carlsson E; Sharif U; Paraoan L. CRISPR/Cas9-mediated one step bi-allelic change of genomic DNA in iPSCs and human RPE cells in vitro with dual antibiotic selection. Sci Rep 9:174 (2019). Su S; Guntur AR; Nguyen DC; Fakory SS; Doucette CC; Leech C; Lotana H; Kelley M; Kohil J; Martino J; Sims-Lucas S; Liaw L; Vary C; Rosen CJ; Brown AC. A Renewable Source of Human Beige Adipocytes for Development of Therapies to Treat Metabolic Syndrome. Cell Reports 25:3215-3228.e9 (2018). Ma L; Hu J; Cao Y; Xie Y; Wang H; Fan Z; Zhang C; Wang J; Wu C-T; Wang S;. Maintained Properties of Aged Dental Pulp Stem Cells for Superior Periodontal Tissue Regeneration. Aging and Disease :https://doi.org/10.14336/AD.2018.0729 (2018). Goa X; Yourick JJ; Sprando RL. Generation of nine induced pluripotent stem cell lines as an ethnic diversity panel. Stem Cell Researchhttps://doi.org/10.1016/j.scr.2018.07.013: (2018) Goa X; Yourick JJ; Sprando RI. Comparative transcriptomic analysis ofendothelial progenitor cells derived from umbilical cord blood and adult peripheral blood: Implications for the generation of induced pluripotent stem cells. Stem Cell Research25:202-212 (2017) Rajasingh S; Thangavel J; Czirok A; Samanta S. "Generation of functional cardiomyocytes from efficiently generated human iPSCs and a novel method for measuring contractility." PLoS one (2015) Poleganov MA; Eminli S; Beissert T; Herz S; Moon J-I; Goldmann J; Beyer A; Heck R; Burkhart I; Roldan DB; Tureci O; Yi K; Hamilton B; Sahin U. Efficient reprogramming of human fibroblasts and blood-derived endothelial progenitor cells using nonmodified RNA for reprogramming and immune evasion. Human Gene Therapy 26:751 (2015) Durruthy JD; Sebastiano V. Derivaton of GMP-compliant integration-free hiPSCs using modified mRNAs. Methods Mol Biol 1283: 31 (2014) Greber, B., Coulon, P., Zhang, M., Moritz, S., Frank, S., Müller-Molina, A.J., Araúzo-Bravo, M.J., Han, D.W., Pape, H.C., and Schöler, H.R. FGF signalling inhibits neural induction in human embryonic stem cells. EMBO J 30: 4874-4884(2011). Sugii, S., Kida, Y., Berggren, W.T., and Evans, R.M. Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells. Nat Protoc 6(3): 346-358 (2011). Warren, L., Manos, P.D., Ahfeldt, T., Loh, Y.H., Li, H., Lau, F., Ebina, W., Mandal, P.K., Smith, Z.D., Meissner, A., Daley, D.Q., Brack, A.S., Collins, J.J., Cowan, C., Schlaeger, T.M., and Rossi, D.J. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7: 618-630 (2010).